ISOP 2022, Scientific Symposium

April 22 to April 23, 2022
Miami Beach, Florida
General information

ISOP 2022 in Miami Beach, Florida sponsored by IBA and RaySearch Laboratories.

This 2-day scientific symposium covers topics such as The State of Proton Therapy in the U.S., Clinical Challenges and Opportunities, Indications and Patient Selection, and Future Technologies. The faculty is made of key opinion leaders in the field, including event co-chairs Jim Metz and Minesh Mehta.

Contacts

Courtney Lundgren
Courtney.Lundgren@iba-group.com
Sales & Marketing Communications Manager
Proton Therapy – North America
IBA

Program
12:10 -12:30

 

The State of Proton Therapy in the U.S.

 

James
Metz
Chair of Penn Medicine Department
Roberts Proton Therapy Center
12:30 - 12:50

Role of Proton Therapy in Radiation Oncology

Minesh
Mehta
Deputy Director & Chief of Radiation Oncology
Miami Cancer Institute​
12:50 - 13:10

RO-APM and Future of PT + Patient Access to PT

Jennifer
Maggiore
Executive Director
National Association for Proton Therapy
1:10 - 1:30

Expanding PT to Community Oncology Practices

Barbara
McAneny
MD
New Mexico Cancer Center
01:30

Coffee Break

1:50 - 2:20

Tips and Considerations for Making PT Projects Successful

Andrew
Wroe
Director Proton Physics
Miami Cancer Institute
Michael
Chuong
Medical Director of Proton Therapy
Baptist Health South Florida
Katherine
Madonna
Associate CFO
UPENN
2:20 - 2:50

Model-based Approach

Hans
Langendijk
Radiation Oncologist
University Medical Center Groningen (UMCG)
2:50 - 3:10

Introduction to IBA PT Solutions

Anthony Jr.
Nagle
IBA
IBA
3:10 - 3:40

(Panel) Single vs. Multi-Room - What's best for the future?

Suresh
Rana
Director of Medical Physics
Lynn Cancer Institute, Boca Raton Regional Hospital, Baptist Health South Florida
Alonso
Gutierrez
AVP, Chief Physicist​
Miami Cancer Institute​
3:40 - 4:00

Managing Organ Motion

Mark
Pankuch
Director of Medical Physics and Dosimetry
Northwestern Medicine Chicago Proton Center
Alonso
Gutierrez
AVP, Chief Physicist​
Miami Cancer Institute​
4:00 - 4:10

QA Resources Necessary for a Proton Center

Anthony
Nagle, Jr
4:10 - 4:30

Effects on Immune System

Jing
Zeng
Medical Director
Proton Therapy Center Seattle Cancer Care Alliance
4:30 - 4:50

Keeping Systems Up to Date - Hyperplatinum

Lei
Dong
Professor, Director of Medical Physics
University of Pennsylvania - Roberts Proton Therapy Center
16:50

Break

9:00 - 9:20

Proton Therapy for Head and Neck Cancer: Selection and management

Brandon
Gunn
MD
Anderson Cancer Center
9:20 - 9:40

Proton Therapy for Central Nervous System & Base of Skull Tumors

Helen
Shih
Medical Director of Proton Therapy
Massachusetts General Hospital
9:40 - 10:00

Pediatric, Proton Therapy: Indications and Patient Selection 

Matthew
Hall
MD, Radiation Oncologist
Baptist Health South Florida
10:00 - 10:20

Breast, The Value of Protons, Cardiotoxicity and RadComp

Shannon
MacDonald
Radiation Oncologist
Massachusetts General Hospital
10:20

Coffee Break

10:40 - 11:00

Proton Therapy for Prostate Cancer: Current Status & Future Directions

Andrew
Lee
M.P.H
Texas Oncology
11:00 - 11:20

GI / Esophagus

Michael
Chuong
Medical Director of Proton Therapy
Baptist Health South Florida
11:20 - 11:50

My Most Challenging Case + Discussion

Wenbo
Gu
PhD. Assistant Professor of Clinical Radiation Oncology
UPENN
Graeme
Williams
MD, Radiation Oncology
UPENN
11:50

Lunch Break on Vista Terrace

12:50 - 1:10

Treatment Planning

Erik
Traneus
Head of Sales Particle Therapy, Senior Physicist
RaySearch Laboratories AB
1:10 - 1:30

A Journey to DynamicARC: recent breakthrough and future roadmap

Xuanfeng (Leo)
Ding
Lead Medical Physicist
Beaumont Health Proton Therapy Center
1:30 - 1:50

The Promise of ConformalFLASH Therapy

Costas
Koumenis
Research Division Director
University of Pennsylvania
1:50 - 2:05

Investing in the Future - IBA Roadmap

Frederic
Genin
President Proton Therapy IBA North America
IBA
2:05 - 2:25

Treatment Adaptation

Rohan L.
Deraniyagala
Radiation Oncologist
Beaumont Proton Therapy Center
2:25 - 2:55

Where is Proton Therapy Headed ?